0.00
Elevation Oncology Inc Azioni (ELEV) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
0.115
|
- | - | - | - |
|
|
24.20%
9.869
|
7.946 | 10.92 | 9.834 | 16.75 |
| Benefits Costs and Expenses |
10.81
|
- | - | - | - |
| Costs And Expenses |
10.81
|
- | - | - | - |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
24.20%
-9.869
|
-7.946 | -10.92 | -9.834 | -16.75 |
| Net Interest Income/Expense |
0.115
|
- | - | - | - |
| Interest Income/Expense After Provision For Losses |
0.115
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
35.56%
-10.70
|
-7.89 | -10.62 | -10.11 | -17.05 |
| Income Tax Expense/Benefit |
22.22%
0.011
|
0.009 | 0.011 | 0.005 | 0.005 |
| Income/Loss From Continuing Operations After Tax |
35.55%
-10.71
|
-7.899 | -10.64 | -10.11 | -17.06 |
|
|
35.55%
-10.71
|
-7.899 | -10.64 | -10.11 | -17.06 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,586%
47.37
|
2.81 | 42.40 | 27.58 | 23.62 |
| Diluted Average Shares |
1,586%
47.37
|
2.81 | 42.40 | 27.58 | 23.62 |
| Basic Earnings Per Share |
76.92%
-0.23
|
-0.13 | -0.25 | -0.37 | -0.72 |
| Diluted Earnings Per Share |
76.92%
-0.23
|
-0.13 | -0.25 | -0.37 | -0.72 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):